Aroa Soriano Fernandez

12PUBLICATIONS
110CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 25, 2026
Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma.

|Jun 10, 2026
SMARCB1 Deficiency in Tumors Confers a Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption.

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|May 29, 2024
In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma.

Catherine Murphy, Laura Devis-Jauregui, Ronja Struck

|Sep 03, 2022
Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program.

Carlos Jiménez, Roberta Antonelli, Mariona Nadal-Ribelles

|Apr 08, 2022
MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment.

Clara Alcon, Fernando Martín, Estela Prada

Pageof 2

Frequent Collaborators

8 joint publications

Miguel Segura

6 joint publications

Soledad Gallego

5 joint publications

Josep Roma

4 joint publications

Lucas Moreno